Background: The brain releases biochemical substrates, such as S100β protein, into circulation in response to ischemic conditions a sign of damage nerve cells and disruption the blood-brain barrier’s integrity. Thrombolytic therapy has led development many neuroprotective therapies phosphatidylcholine, phosphatidylserine, inulin, which can be added food products. Protein, phospholipids, have im...
